Table 4 Numbers and proportions of different lesions according to the Bethesda 2001 classification, per study group
|  | Group 1 (n = 131) | Group 2 (n = 128) | Group 3 (n = 539) | Group 4 (n = 220) | Total (n = 1018) |
|---|---|---|---|---|---|
HIV screening centres | HIV screening centres | Hospitals | Health centres | ||
HIV-positive women | HIV-negative women | HIV status unknown | HIV status unknown | ||
| Â | n (%) | n (%) | n (%) | n (%) | 1018 (%) |
NILM | 80 (61.1) | 117 (91.4) | 449 (83.3) | 188 (85.5) | 834 (81.9) |
ASCUS | 9 (6.9) | 5 (3.9) | 46 (8.5) | 19 (8.6) | 79 (7.8) |
ASC-H | 1 (0.8) | 1 (0.8) | 23 (4.3) | 4 (1.8) | 29 (2.9) |
LSIL | 2 (1.5) | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (0.2) |
HSIL | 30 (22.9) | 5 (3.9) | 17 (3.2) | 5 (2.3) | 57 (5.6) |
Ca | 9 (6.9) | 0 (0.0) | 4 (0.7) | 4 (1.8) | 17 (1.7) |
Subtotal: LSIL+ | 41 (31.3) | 5 (3.9) | 21 (3.9) | 9 (4.1) | 76 (7.5) |